Cardlytics, Inc. — Director's Dealing 2023

Sep 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2023-09-01

Reporting Person: Temsamani Karim Saad (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-01	Common Stock	M	336315	—	Acquired	360741	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-09-01	Restricted Stock Unit	$	M	336315	Disposed		Common Stock (336315)	Direct

Footnotes

F1: Represents the underlying vested shares of common stock of the Issuer.

F2: Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.

F3: 25% of the RSUs vested on September 1, 2023 with the remaining 75% vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.